- Home
- Publications
- Publication Search
- Publication Details
Title
The Controversial Role of IL-33 in Lung Cancer
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-05-12
DOI
10.3389/fimmu.2022.897356
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The roles of interleukin‐1 receptor accessory protein in certain inflammatory conditions
- (2022) Ali Zarezadeh Mehrabadi et al. IMMUNOLOGY
- Reciprocal regulation of IL-33 receptor–mediated inflammatory response and pulmonary fibrosis by TRAF6 and USP38
- (2022) Xue-Mei Yi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer Statistics, 2021
- (2021) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Small-cell lung cancer
- (2021) Charles M. Rudin et al. Nature Reviews Disease Primers
- IL-33 Promotes the Growth of Non-Small Cell Lung Cancer Cells Through Regulating miR-128-3p/CDIP1 Signalling Pathway
- (2021) Xiaorong Zhou et al. Cancer Management and Research
- Neoadjuvant immunotherapy for non–small cell lung cancer: State of the art
- (2021) Jin Kang et al. Cancer Communications
- PPARɣ drives IL-33-dependent ILC2 pro-tumoral functions
- (2021) Giuseppe Ercolano et al. Nature Communications
- First‐Line Pembrolizumab Versus Chemotherapy in Metastatic Non–Small‐Cell Lung Cancer: KEYNOTE‐024 Japan Subset
- (2021) Miyako Satouchi et al. CANCER SCIENCE
- IL‐33 activates mTORC1 and modulates glycolytic metabolism in CD8 + T cells
- (2021) Yuejin Liang et al. IMMUNOLOGY
- Molecular Basis of Selective Cytokine Signaling Inhibition by Antibodies Targeting a Shared Receptor
- (2021) James K. Fields et al. Frontiers in Immunology
- IL-33, an Alarmin of the IL-1 Family Involved in Allergic and Non Allergic Inflammation: Focus on the Mechanisms of Regulation of Its Activity
- (2021) Corinne Cayrol Cells
- IL33 activates CD8+T and NK cells through MyD88 pathway to suppress the lung cancer cell growth in mice
- (2020) Longsheng Xu et al. BIOTECHNOLOGY LETTERS
- ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity
- (2020) John Alec Moral et al. NATURE
- New insights into small‐cell lung cancer development and therapy
- (2020) Yuwen Wang et al. CELL BIOLOGY INTERNATIONAL
- Unique Phenotypes of Heart Resident Type 2 Innate Lymphoid Cells
- (2020) Yafei Deng et al. Frontiers in Immunology
- Systemic administration of IL‐33 induces a population of circulating KLRG1 hi type 2 innate lymphoid cells and inhibits type 1 innate immunity against multiple myeloma
- (2020) Camille Guillerey et al. IMMUNOLOGY AND CELL BIOLOGY
- COX Inhibition Increases Alternaria-Induced Pulmonary Group 2 Innate Lymphoid Cell Responses and IL-33 Release in Mice
- (2020) Weisong Zhou et al. JOURNAL OF IMMUNOLOGY
- ILC2-driven innate immune checkpoint mechanism antagonizes NK cell antimetastatic function in the lung
- (2020) Martijn J. Schuijs et al. NATURE IMMUNOLOGY
- Epithelial-Mesenchymal Transition in Asthma Airway Remodeling Is Regulated by the IL-33/CD146 Axis
- (2020) Zhixiao Sun et al. Frontiers in Immunology
- Fibroblast-derived IL-33 facilitates breast cancer metastasis by modifying the immune microenvironment and driving type-2 immunity
- (2020) Ophir Shani et al. CANCER RESEARCH
- Oesophageal squamous cell carcinoma–associated IL‐33 rewires macrophage polarization towards M2 via activating ornithine decarboxylase
- (2020) Shijie Mai et al. CELL PROLIFERATION
- Measuring the Integration of Stereotactic Ablative Radiotherapy Plus Surgery for Early-Stage Non–Small Cell Lung Cancer
- (2019) David A. Palma et al. JAMA Oncology
- IL-33 drives the antitumour effects of dendritic cells via upregulating CYLD expression in pulmonary adenocarcinoma
- (2019) Jiguang Zhang et al. Artificial Cells Nanomedicine and Biotechnology
- Akt1 regulates pulmonary fibrosis via modulating IL-13 expression in macrophages
- (2019) Yunjuan Nie et al. Innate Immunity
- Non–Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment
- (2019) Narjust Duma et al. MAYO CLINIC PROCEEDINGS
- Targeting ST2 expressing activated regulatory T cells in Kras-mutant lung cancer
- (2019) Byung-Seok Kim et al. OncoImmunology
- Interleukin‐33 activates and recruits natural killer cells to inhibit pulmonary metastatic cancer development
- (2019) Lu Qi et al. INTERNATIONAL JOURNAL OF CANCER
- Rab37 in lung cancer mediates exocytosis of soluble ST2 and thus skews macrophages toward tumor-suppressing phenotype
- (2018) Hong-Tai Tzeng et al. INTERNATIONAL JOURNAL OF CANCER
- Lower expression level of IL-33 is associated with poor prognosis of pulmonary adenocarcinoma
- (2018) Min Yang et al. PLoS One
- Interleukin-33 enhanced the migration and invasiveness of human lung cancer cells
- (2018) Zhiping Yang et al. OncoTargets and Therapy
- IL‑33 notably inhibits the growth of colon cancer cells
- (2018) Xuhui Chen et al. Oncology Letters
- Type 2 Innate Lymphocytes Actuate Immunity Against Tumours and Limit Cancer Metastasis
- (2018) Iryna Saranchova et al. Scientific Reports
- The Role of IL-33/ST2 Pathway in Tumorigenesis
- (2018) Kristen Larsen et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Which is the optimal immunotherapy for advanced squamous non-small-cell lung cancer in combination with chemotherapy: anti-PD-1 or anti-PD-L1?
- (2018) Yaxiong Zhang et al. Journal for ImmunoTherapy of Cancer
- IL-33: biological properties, functions, and roles in airway disease
- (2017) Li Yin Drake et al. IMMUNOLOGICAL REVIEWS
- Interleukin-33 (IL-33): A nuclear cytokine from the IL-1 family
- (2017) Corinne Cayrol et al. IMMUNOLOGICAL REVIEWS
- AKT2 Regulates Pulmonary Inflammation and Fibrosis via Modulating Macrophage Activation
- (2017) Yunjuan Nie et al. JOURNAL OF IMMUNOLOGY
- Prophylactic cranial irradiation versus observation in patients with extensive-disease small-cell lung cancer: a multicentre, randomised, open-label, phase 3 trial
- (2017) Toshiaki Takahashi et al. LANCET ONCOLOGY
- Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy
- (2017) Lais Osmani et al. SEMINARS IN CANCER BIOLOGY
- Wounds that heal and wounds that don’t − The role of the IL-33/ST2 pathway in tissue repair and tumorigenesis
- (2017) Neal L. Millar et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- IL-33 blockade suppresses tumor growth of human lung cancer through direct and indirect pathways in a preclinical model
- (2017) Kailing Wang et al. Oncotarget
- The ST2/IL-33 Axis in Immune Cells during Inflammatory Diseases
- (2017) Brad Griesenauer et al. Frontiers in Immunology
- IL-33 restricts tumor growth and inhibits pulmonary metastasis in melanoma-bearing mice through eosinophils
- (2017) Valeria Lucarini et al. OncoImmunology
- Time course of changes in oxidative stress and stress-induced proteins in cardiomyocytes exposed to doxorubicin and prevention by vitamin C
- (2017) Ana Ludke et al. PLoS One
- IL-33 signaling fuels outgrowth and metastasis of human lung cancer
- (2016) Chunhong Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Loss of epithelial Gq and G11 signaling inhibits TGF production but promotes IL-33-mediated macrophage polarization and emphysema
- (2016) A. E. John et al. Science Signaling
- Interleukin-33 enhances programmed oncosis of ST2L-positive low-metastatic cells in the tumour microenvironment of lung cancer
- (2016) M Akimoto et al. Cell Death & Disease
- Exogenous IL-33 overcomes T cell tolerance in murine acute myeloid leukemia
- (2016) Lei Qin et al. Oncotarget
- Loss of epithelial Gq and G11 signaling inhibits TGF production but promotes IL-33-mediated macrophage polarization and emphysema
- (2016) A. E. John et al. Science Signaling
- Management of Small Cell Lung Cancer
- (2015) Mehmet Altan et al. CANCER JOURNAL
- The role of IL-33/ST2L signals in the immune cells
- (2015) Jingli Lu et al. IMMUNOLOGY LETTERS
- Impact of Specific Epidermal Growth Factor Receptor (EGFR) Mutations and Clinical Characteristics on Outcomes After Treatment With EGFR Tyrosine Kinase Inhibitors Versus Chemotherapy inEGFR-Mutant Lung Cancer: A Meta-Analysis
- (2015) Chee Khoon Lee et al. JOURNAL OF CLINICAL ONCOLOGY
- Survival After Sublobar Resection versus Lobectomy for Clinical Stage IA Lung Cancer
- (2015) Onkar V. Khullar et al. Journal of Thoracic Oncology
- Circulating IL-33 level is associated with the progression of lung cancer
- (2015) Myung Shin Kim et al. LUNG CANCER
- Small cell lung cancer: Where do we go from here?
- (2014) Lauren Averett Byers et al. CANCER
- IL-33: an alarmin cytokine with crucial roles in innate immunity, inflammation and allergy
- (2014) Corinne Cayrol et al. CURRENT OPINION IN IMMUNOLOGY
- IL-33 promotes ST2-dependent lung fibrosis by the induction of alternatively activated macrophages and innate lymphoid cells in mice
- (2014) Dong Li et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The alarmin IL-33 promotes regulatory T-cell function in the intestine
- (2014) Chris Schiering et al. NATURE
- Central domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cells
- (2014) E. Lefrancais et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Reactive oxygen species at the crossroads of inflammasome and inflammation
- (2014) Anantha Harijith et al. Frontiers in Physiology
- Serum IL-33 as a Diagnostic and Prognostic Marker in Non-small Cell Lung Cancer
- (2013) Liang-An Hu et al. Asian Pacific Journal of Cancer Prevention
- Transgenic expression of IL-33 activates CD8+ T cells and NK cells and inhibits tumor growth and metastasis in mice
- (2013) Kun Gao et al. CANCER LETTERS
- IL-33/IL-31 axis: A new pathological mechanisms for EGFR tyrosine kinase inhibitors-associated skin toxicity
- (2013) Sebastiano Gangemi et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Long-term IL-33–producing epithelial progenitor cells in chronic obstructive lung disease
- (2013) Derek E. Byers et al. JOURNAL OF CLINICAL INVESTIGATION
- Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma WithEGFRMutations
- (2013) Lecia V. Sequist et al. JOURNAL OF CLINICAL ONCOLOGY
- Interleukin 33 as a Mechanically Responsive Cytokine Secreted by Living Cells
- (2012) Rahul Kakkar et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Activation of Eosinophils Interacting with Dermal Fibroblasts by Pruritogenic Cytokine IL-31 and Alarmin IL-33: Implications in Atopic Dermatitis
- (2012) Chun-Kwok Wong et al. PLoS One
- IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G
- (2012) E. Lefrancais et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer cells that survive radiation therapy acquire HIF-1 activity and translocate towards tumour blood vessels
- (2012) Hiroshi Harada et al. Nature Communications
- The Danger Signal, Extracellular ATP, Is a Sensor for an Airborne Allergen and Triggers IL-33 Release and Innate Th2-Type Responses
- (2011) Hideaki Kouzaki et al. JOURNAL OF IMMUNOLOGY
- Predictors and Outcomes of Limited Resection for Early-Stage Non-Small Cell Lung Cancer
- (2011) S. E. Billmeier et al. JNCI-Journal of the National Cancer Institute
- Increased IL-33 expression by epithelial cells in bronchial asthma
- (2010) David Préfontaine et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Roles for Growth Factors in Cancer Progression
- (2010) Esther Witsch et al. PHYSIOLOGY
- The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-γ production
- (2009) Elvire Bourgeois et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Increased Expression of IL-33 in Severe Asthma: Evidence of Expression by Airway Smooth Muscle Cells
- (2009) D. Prefontaine et al. JOURNAL OF IMMUNOLOGY
- Small Cell Lung Cancer
- (2009) Taimur Sher et al. MAYO CLINIC PROCEEDINGS
- Structure of IL-33 and Its Interaction with the ST2 and IL-1RAcP Receptors—Insight into Heterotrimeric IL-1 Signaling Complexes
- (2009) Andreas Lingel et al. STRUCTURE
- Molecular mimicry between IL-33 and KSHV for attachment to chromatin through the H2A–H2B acidic pocket
- (2008) Lucie Roussel et al. EMBO REPORTS
- Outcomes of Risk-Adapted Fractionated Stereotactic Radiotherapy for Stage I Non–Small-Cell Lung Cancer
- (2008) Frank J. Lagerwaard et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started